Ayurvedic treatment of Allergic Rhinitis

Phase 2

Completed

• Conditions: Health Condition 1: null- Allergic Rhinitis

• Registration Number: CTRI/2017/12/010937
• Lead Sponsor: CCRAS

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2017-04-10
• Last Update Posted: 17 October 2022

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 107

Inclusion Criteria

Patients either sex aged between 18 to 65 years.

2. Clinical diagnosis persisting symptoms of Allergic rhinitis, X-ray (PNS), Nasal endoscopy and laboratory investigations etc.

3. Able and willing to participate and provide signed informed consent.

Exclusion Criteria

1.History of chronic nasal or upper respiratory tract symptoms or disorders other than allergic rhinitis.

2.History of non allergic rhinitis, chronic sinusitis or serve asthma.

3.Patients with nasal anatomical defects (deviated nasal septum).

4.Patients with acute episodes i.e. fever/earache/headache.

5.Patients with associated tonsillitis or airway obstructions (adenoids).

6.Has a nasal condition likely to affect the outcome of the study.

7.Any treatment of H1 antihistamine medication, Non-steroidal analgesies. Corticosteroids Nasal drops, Leukotriene antagonists, Nasal vasoconstrictors.

8.Pregnant ladies and Lactating mothers.

9.Patients suffering from any debilitating chronic disease like tuberculosis, Uncontrolled Diabetes mellitus

10.Any unstable cardio-vascular diseases

11.Patients with evidence of malignancy.

12.Patients with concurrent hepatic disorder (defined as Aspartate Amino Transferase (AST) and / or Alanine Amino Transferase (ALT) > 2 times upper normal limit or Renal Disorders (defined as S. creatinine > upper limit of Lab. value), Pulmonary Dysfunction (Bronchial Asthma and / or Chronic Obstructive Pulmonary Disease [COPD])

13.Patient has an acute mental disorder

14.Patients who are currently participating in any other clinical trial.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To evaluate the effect of Ayurvedic formulation in terms of Control of Allergic Rhinitis and Asthma TestTimepoint: one month

Secondary Outcome Measures

Name	Time	Method
ot applicableTimepoint: Not applicable